CRISM Therapeutics (CRTX) Competitors GBX 8 -1.50 (-15.79%) As of 09:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock CRTX vs. VAST, BZT, ORM, PFP, GROC, THR, JAN, SKA, REE, and TYMShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Vast Resources (VAST), Bezant Resources (BZT), Ormonde Mining (ORM), Pathfinder Minerals (PFP), GreenRoc Mining (GROC), Thor Energy (THR), Jangada Mines (JAN), Shuka Minerals (SKA), Altona Rare Earths (REE), and Tertiary Minerals (TYM). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Vast Resources Bezant Resources Ormonde Mining Pathfinder Minerals GreenRoc Mining Thor Energy Jangada Mines Shuka Minerals Altona Rare Earths Tertiary Minerals CRISM Therapeutics (LON:CRTX) and Vast Resources (LON:VAST) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations. Do insiders & institutionals believe in CRTX or VAST? 11.7% of Vast Resources shares are held by institutional investors. 68.8% of CRISM Therapeutics shares are held by company insiders. Comparatively, 54.1% of Vast Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is CRTX or VAST more profitable? CRISM Therapeutics has a net margin of 0.00% compared to Vast Resources' net margin of -278.08%. CRISM Therapeutics' return on equity of -13.12% beat Vast Resources' return on equity.Company Net Margins Return on Equity Return on Assets CRISM TherapeuticsN/A -13.12% -26.77% Vast Resources -278.08%-339.02%-24.18% Does the MarketBeat Community favor CRTX or VAST? Vast Resources received 84 more outperform votes than CRISM Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformCRISM TherapeuticsN/AN/AVast ResourcesOutperform Votes8464.62% Underperform Votes4635.38% Which has preferable valuation and earnings, CRTX or VAST? CRISM Therapeutics has higher earnings, but lower revenue than Vast Resources. Vast Resources is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCRISM TherapeuticsN/AN/A-£792.20K-£5.81-1.38Vast Resources£3.58M1.33-£9.95M-£0.01-26.30 Does the media prefer CRTX or VAST? In the previous week, Vast Resources had 1 more articles in the media than CRISM Therapeutics. MarketBeat recorded 1 mentions for Vast Resources and 0 mentions for CRISM Therapeutics. CRISM Therapeutics' average media sentiment score of 1.17 beat Vast Resources' score of -0.30 indicating that CRISM Therapeutics is being referred to more favorably in the media. Company Overall Sentiment CRISM Therapeutics Positive Vast Resources Neutral Which has more risk and volatility, CRTX or VAST? CRISM Therapeutics has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Vast Resources has a beta of 2.56, indicating that its share price is 156% more volatile than the S&P 500. SummaryVast Resources beats CRISM Therapeutics on 7 of the 13 factors compared between the two stocks. Remove Ads Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£872,000.00£962.20M£2.97B£2.47BDividend YieldN/A6.19%5.23%4.95%P/E Ratio-1.3848.7676.87130.51Price / SalesN/A21,088.2222,994,579,948,144,900.00230,385.31Price / CashN/A25.1624.3227.95Price / Book0.197.505.314.42Net Income-£792,204.93£70.70M£154.96M£5.79B7 Day PerformanceN/A8.17%6.26%5.37%1 Month Performance29.85%9.41%3.28%3.79%1 Year PerformanceN/A40.27%16.60%104.20% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 8-15.8%N/AN/A£872,000.00N/A-1.384Positive NewsGap UpVASTVast ResourcesN/AGBX 0.23flatN/A-43.0%£4.16M£3.58M-23.00350News CoverageBZTBezant ResourcesN/AGBX 0.02flatN/A+9.1%£3.81MN/A-458.025Gap DownORMOrmonde MiningN/AN/AN/AN/A£3.54MN/A-2.506PFPPathfinder MineralsN/AN/AN/AN/A£2.92MN/A-5.255GROCGreenRoc MiningN/AGBX 1.51+11.5%N/A-10.7%£2.91MN/A-1.956THRThor EnergyN/AGBX 0.54+2.9%N/A-62.1%£2.58MN/A-0.771,083Gap UpHigh Trading VolumeJANJangada MinesN/AGBX 0.65-7.1%N/A-54.8%£2.10MN/A-3,150.751Positive NewsGap UpSKAShuka MineralsN/AGBX 3-7.7%N/A-65.9%£2.07M£146,074.23-1.2923Gap DownREEAltona Rare EarthsN/AGBX 1.20-0.2%N/A-12.2%£1.95MN/A-39.93270TYMTertiary MineralsN/AGBX 0.05+11.1%N/A-60.9%£1.87M£310,433.86-1.995News CoverageGap Up Remove Ads Related Companies and Tools Related Companies Vast Resources Alternatives Bezant Resources Alternatives Ormonde Mining Alternatives Pathfinder Minerals Alternatives GreenRoc Mining Alternatives Thor Energy Alternatives Jangada Mines Alternatives Shuka Minerals Alternatives Altona Rare Earths Alternatives Tertiary Minerals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRTX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCould this be the start of AI’s Second Wind?We're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryThe crypto summit Wall Street wants to stop Learn how to structure your portfolio like the top hedge funds...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRTX Stock Free CRTX Stock Alerts